Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Sanofi Files NDA for Prostate Cancer Treatment Cabazitaxel in Japan
August 2, 2013
- Prospects for World’s 1st FD Treatment Remain Unclear; Success Will Depend on Raising Awareness, Role of Endoscopy
August 2, 2013
- Pfizer, Takeda Launch RA Treatment Xeljanz, Prepare for Promoting Proper Use of Drug
August 1, 2013
- Takeda Paid 40 billion Yen to Healthcare Professionals in FY2012
August 1, 2013
- 2 Beijing-Based Wholesalers Could Serve as Point of Contact for Japanese Drug Makers: Mr Yoda of Medipal Holdings
August 1, 2013
- PII Study of Renal Anemia Treatment Codeveloped by FibroGen Starts in Japan: Astellas
August 1, 2013
- Sanofi K.K.’s Payments to Healthcare Professionals Total 9.8 Billion Yen in 2012
July 31, 2013
- Ex-Novartis Employee Had Access to Pre-Locked Data: Third-Party Probe
July 31, 2013
- Novartis Paid 23.6 Billion Yen to Doctors, Medical and Research Institutions in 2012
July 31, 2013
- Novartis’s Third-Party Probe Finds “No Evidence” Indicating Data Falsification by Ex-Employee; Truth behind Diovan Woe Not Yet Uncovered
July 30, 2013
- Arbekacin Inhalation Solution Enters PI Study in US: Meiji Seika Pharma
July 30, 2013
- Medipal, Mitsubishi Acquire Shares in Chinese Pharma Wholesaler for 8 Billion Yen
July 30, 2013
- Janssen Files NDA for Prostate Cancer Treatment Abiraterone in Japan
July 30, 2013
- Kyowa Kirin’s 1st Half Sales Up 2.1%, but Mainstay Nesp Slumps 7%
July 29, 2013
- Interim Analysis of Multinational PIII Study of Orteronel Shows No Improvement of OS in Patients with mCRPC: Takeda
July 29, 2013
- Bell Medical, inVentiv to Provide Promotion and PMS Support Services
July 26, 2013
- Chugai Sales Up 8.4% Due to Increase in Cancer Treatment, Overseas Sales
July 26, 2013
- Safety of Atopic Dermatitis Treatment Confirmed in PI Study in Japan: AnGes MG
July 26, 2013
- OncoTherapy, Panasonic Healthcare to Codevelop Immune Monitoring System to Evaluate Effects of Cancer Vaccines
July 26, 2013
- Can Generic Drug Industry Achieve “Zero Supply Disruptions” by FY2015? 30 Products –Largest Ever– from 14 Companies Experience Shortage in 2012
July 26, 2013
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…